Почетна › Рак простате › Arkanzas
Kliničke studije za Рак простате u državi Arkanzas
13 studija za Рак простате traži učesnike na lokacijama u državi Arkanzas.
Gradovi u državi Arkanzas
Zvanični tekst studije (na engleskom)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Mercy Hospital Fort Smith, Fort Smith
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mercy Hospital Fort Smith, Fort Smith
- CARTI Cancer Center, Little Rock
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Research Site, Fayetteville
Тражи се учесникФаза 1/2
Узраст од 18 до 130 · Мушкарци · Ажурирано 22. 10. 2026. · NCT07181161Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
- Research Site, Hot Springs
- Research Site, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 15. 10. 2026. · NCT07711002This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
- Highlands Oncology Group, PA, Fayetteville
- Highlands Oncology Group, PA, Rogers
- Highlands Oncology Group, PA, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 14. 10. 2026. · NCT07028853Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Arkansas Urology Research Center, LLC, Little Rock
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 11. 9. 2026. · NCT06056830Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
- University of Arkansas for Medical Sciences, Little Rock
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 8. 9. 2026. · NCT07224009AI Algorithm-Informed Biopsy for Prostate Cancer Detection With Indeterminate and Low-Risk Prostate MRI Lesions
- University of Arkansas for Medical Sciences, Little Rock
Тражи се учесник
Узраст 40 и старији · Мушкарци · Ажурирано 19. 8. 2026. · NCT07231627Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- Proton Center of Arkansas, Little Rock
Тражи се учесник
Узраст 18 и старији · Мушкарци · Ажурирано 17. 6. 2026. · NCT00969111Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
- Highlands Oncology Group - Fayetteville, Fayetteville
- Highlands Oncology Group - Rogers, Rogers
- Highlands Oncology Group, Springdale
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 22. 1. 2026. · NCT06470243SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Little Rock
Тражи се учесникОпсервациона студија
Сви узрасти · Оба пола · Ажурирано 28. 10. 2025. · NCT03452774Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.